Literature DB >> 2957002

Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors.

D H Ryan, C W Chapple, S A Kossover, A A Sandberg, H J Cohen.   

Abstract

Expression of differentiation markers in common acute lymphoblastic leukemia (cALL) cells from 25 patients was compared with subpopulations of normal common ALL antigen (CALLA) (CD10)-positive bone marrow lymphoid cells (cBMLs). In cBML, CD10 intensity is positively correlated with CD34 (MY10) and terminal transferase (TdT) expression and inversely correlated with common leukocyte antigen (CLA), CD20 (B1), and ctyoplasmic mu chain (Cmu) expression. In cALL, CD10 density was inversely correlated with CLA and Cmu expression and strongly correlated with CD34 expression as in cBML. In contrast to cBML, TdT and CD20 expression were not related to CD10 density in cALL. Furthermore, cALL TdT intensity measured by enzyme immunoassay was not related to expression of CD10, CLA, or CD34, but was positively correlated with CD20 expression. Cmu expression in cALL was inversely correlated with expression of CD34 and positively correlated with CLA as in cBML, but showed no association with TdT intensity or CD20 expression in contrast to the relationship found in cBMLs. Analysis of TdT intensity and Cmu expression in sorted subpopulations of cells from individual patients that were positive or negative for CD34, CD20, or CD10 was consistent with the data obtained by comparison of cells from different patients. These results indicate that from patient to patient and within individual patients, cALL cells express the markers CD34, CLA, CD10, and Cmu in a coordinated fashion similar to cBMLs, but demonstrate differences in expression of TdT and CD20 with respect to the marrow cells considered their normal counterparts. The cALL cells that are CD34 positive show increased expression of CD10 and are less likely to be CLA or Cmu positive, suggesting that they may represent a phenotypically less differentiated form of cALL than does CD34-negative cALL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957002

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Routine immunophenotyping of acute leukemias.

Authors:  W D Ludwig; E Thiel
Journal:  Blut       Date:  1990-01

2.  Antigen CD34+ marrow cells engraft lethally irradiated baboons.

Authors:  R J Berenson; R G Andrews; W I Bensinger; D Kalamasz; G Knitter; C D Buckner; I D Bernstein
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

3.  Telomeric DNA in normal and leukemic blood cells.

Authors:  O Yamada; K Oshimi; T Motoji; H Mizoguchi
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

4.  Expression of CD34 on human B cell precursors.

Authors:  C Schmitt; C J Eaves; P M Lansdorp
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 5.  A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer.

Authors:  Rosario Perona; Blanca D López-Ayllón; Javier de Castro Carpeño; Cristóbal Belda-Iniesta
Journal:  Clin Transl Oncol       Date:  2011-05       Impact factor: 3.405

6.  Increase of CALLA-positive stimulated lymphoid cells in transient erythroblastopenia of childhood.

Authors:  S Leuschner; S Bödewaldt-Radzun; M Rister
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

7.  Lung cancer stem cell: new insights on experimental models and preclinical data.

Authors:  Caroline Rivera; Sofia Rivera; Yohann Loriot; Marie-Catherine Vozenin; Eric Deutsch
Journal:  J Oncol       Date:  2010-12-16       Impact factor: 4.375

8.  Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity.

Authors:  C V Jongeneel; E J Quackenbush; P Ronco; P Verroust; S Carrel; M Letarte
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

9.  Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties.

Authors:  R G Andrews; J W Singer; I D Bernstein
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Cancer stem cells in breast cancer.

Authors:  Ryou-U Takahashi; Fumitaka Takeshita; Tomohiro Fujiwara; Makiko Ono; Takahiro Ochiya
Journal:  Cancers (Basel)       Date:  2011-03-15       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.